Literature DB >> 17166095

Stem cells from umbilical cord blood differentiate into myotubes and express dystrophin in vitro only after exposure to in vivo muscle environment.

Viviane A Nunes1, Natale Cavaçana, Martha Canovas, Bryan E Strauss, Mayana Zatz.   

Abstract

BACKGROUND INFORMATION: Duchenne muscular dystrophy is a disease characterized by progressive and irreversible muscle degeneration for which there is no therapy. HUCB (human umbilical cord blood) has been considered as an important source of haematopoietic and mesenchymal stem cells, each having been shown to differentiate into distinct cell types. However, it remains unclear if these cells are able to differentiate into muscle cells.
RESULTS: We have showed that stem cells from HUCB did not differentiate into myotubes or express dystrophin when cultured in muscle-conditioned medium or with human muscle cells. However, delivery of GFP (green fluorescent protein)-transduced mononucleated cells from HUCB, which comprises both haematopoietic and mesenchymal populations, into quadriceps muscle of mdx (mouse dystrophy X-chromosome linked) mice resulted in the expression of human myogenic markers. After recovery of these cells from mdx muscle and in vitro cultivation, they were able to fuse and form GFP-positive myotubes that expressed dystrophin.
CONCLUSIONS: These results indicate that chemical factors and cell-to-cell contact provided by in vitro conditions were not enough to trigger the differentiation of stem cells into muscle cells. Nevertheless, we showed that the HUCB-derived stem cells were capable of acquiring a muscle phenotype after exposure to an in vivo muscle environment, which was required to activate the differentiation programme.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17166095     DOI: 10.1042/BC20060075

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  9 in total

1.  Human umbilical cord-derived mesenchymal stem cells differentiate into epidermal-like cells using a novel co-culture technique.

Authors:  Dongjie Li; Jiake Chai; Chuanan Shen; Yanfu Han; Tianjun Sun
Journal:  Cytotechnology       Date:  2014-06-21       Impact factor: 2.058

Review 2.  Stem cell researches in Brazil: present and future challenges.

Authors:  Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2009-02-19       Impact factor: 5.739

3.  Autophagy induction in the skeletal myogenic differentiation of human tonsil-derived mesenchymal stem cells.

Authors:  Saeyoung Park; Yoonyoung Choi; Namhee Jung; Jieun Kim; Seiyoon Oh; Yeonsil Yu; Jung-Hyuck Ahn; Inho Jo; Byung-Ok Choi; Sung-Chul Jung
Journal:  Int J Mol Med       Date:  2017-02-20       Impact factor: 4.101

4.  Human Umbilical Cord Mesenchymal Stem Cells Extricate Bupivacaine-Impaired Skeletal Muscle Function via Mitigating Neutrophil-Mediated Acute Inflammation and Protecting against Fibrosis.

Authors:  Wen-Hong Su; Ching-Jen Wang; Hung-Chun Fu; Chien-Ming Sheng; Ching-Chin Tsai; Jai-Hong Cheng; Pei-Chin Chuang
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

Review 5.  Tissue engineering strategies combining molecular targets against inflammation and fibrosis, and umbilical cord blood stem cells to improve hampered muscle and skin regeneration following cleft repair.

Authors:  Michaël Schreurs; C Maarten Suttorp; Henricus A M Mutsaers; Anne Marie Kuijpers-Jagtman; Johannes W Von den Hoff; Edwin M Ongkosuwito; Paola L Carvajal Monroy; Frank A D T G Wagener
Journal:  Med Res Rev       Date:  2019-05-18       Impact factor: 12.944

6.  Stem cells from umbilical cord blood do have myogenic potential, with and without differentiation induction in vitro.

Authors:  Tatiana Jazedje; Mariane Secco; Natássia M Vieira; Eder Zucconi; Thomaz R Gollop; Mariz Vainzof; Mayana Zatz
Journal:  J Transl Med       Date:  2009-01-14       Impact factor: 5.531

7.  Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice.

Authors:  Yong Li; Cheng Zhang; Fu Xiong; Mei-juan Yu; Fu-Lin Peng; Yan-chang Shang; Cui-ping Zhao; Yong-feng Xu; Zheng-shan Liu; Chang Zhou; Jin-lang Wu
Journal:  BMC Cell Biol       Date:  2008-05-19       Impact factor: 4.241

Review 8.  Fetal stem cells and skeletal muscle regeneration: a therapeutic approach.

Authors:  Michela Pozzobon; Chiara Franzin; Martina Piccoli; Paolo De Coppi
Journal:  Front Aging Neurosci       Date:  2014-08-27       Impact factor: 5.750

9.  Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration.

Authors:  Saeyoung Park; Yoonyoung Choi; Namhee Jung; Yeonsil Yu; Kyung-Ha Ryu; Han Su Kim; Inho Jo; Byung-Ok Choi; Sung-Chul Jung
Journal:  Int J Mol Med       Date:  2016-03-22       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.